So far, only a few case-studies have been tried using neurofeedback in the treatment of dementia / cognitive decline. These indicate that there are behavioural changes and emotional changes next to cognitive changes. This will be the focus of this…
ID
Source
Brief title
Condition
- Dementia and amnestic conditions
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primaire primary study parameters in this study will be the psychological
(depression, behaviour), fysiological (EEG) and cognitive (memory, attention)
variables. Further, we will measur changes in Quality of Live.
Secondary outcome
nvt
Background summary
The number of people with dementia and cognitive decline will grow in the
coming years. As a consequence, the demand for care and the costs of care will
increase.
The existing treatments for dementia are few and sadly not very effective.
Recently a new form of treatment has been developed that may be a good
alternative. Neurofeedback, a treatment method that works through operant
conditioning of the EEG has been proven to enhance attention and memory in
healthy subject and subjects diagnosed with AD(H)D. The goal of this research
is to find out if neurofeedback can improve functioning in people suffering
from cognitive decline.
Recently, changes in EEG in cognitive decline have been described. This gives a
possibility for neurofeedback to change these patterns.
Study objective
So far, only a few case-studies have been tried using neurofeedback in the
treatment of dementia / cognitive decline. These indicate that there are
behavioural changes and emotional changes next to cognitive changes. This will
be the focus of this research; we hope that there will changes in the EEG
(physiological changes), psychological changes and cognitive changes.
Study design
The design of the study is a RCT with a cross-over design. The control group
recieves treatment as usual, the experimental group treatment as usual plus
neurofeedback. There will also be a healthy control group.
Intervention
The intervention group will receive 30 session of neurofeedback, twice a week.
The controlgroup recieves treatment as usual. After 30 sessions, the groups
will switch. The healthy controls do not have a "waitinglist" condition.
Study burden and risks
Before and after the treatment sessions participants will undergo an
EEG-examination. This, together with the fact that participants will have to
come to the hospital twice a week, will be the greatest burden on the
participants. Further, the participants will have to complete a few
questionnaires and a short neuropsychological screening, which is mostly part
of the standard procedure of the *geheugen onderzoek centrum*.
Michelangelolaan ` 2
Eindhoven 5623 EJ
NL
Michelangelolaan ` 2
Eindhoven 5623 EJ
NL
Listed location countries
Age
Inclusion criteria
Diagnosis: Cognitve decline as diagnosed by the Catharina hospitals memory clinic .
Healthy controls
Exclusion criteria
Neurological history (epilepsy, strike, braintumors)
impaired vision or hearing (glasses or hearingaid is not sufficient for vision or hearing)
Insufficient knowledge of the dutch language
The patients EEG and qEEG do not meet the criteria as discribed in the literature
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL25685.060.08 |